Publications by authors named "Devra J Olson"

Claim this Profile
T
Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models.
David R Gruber, Elizabeth J Cummins, Weiping Zeng, Michelle Ulrich, Kaleb Smith, Devra J Olson

Mol Cancer Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PF-08046032: A Novel, Investigational CD25-Directed Antibody-Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors.
Sherif Abdelhamed, Xinqun Zhang, Weiping Zeng, Bryan Grogan, Luke Schilperoort, Devra J Olson

Mol Cancer Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models.
Rebecca Mazahreh, Marsha L Mason, John J Gosink, Devra J Olson, Robert Thurman

Mol Cancer Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis